Medical aesthetic device company Candela has signed an exclusive collaboration agreement to commercialise MT.DERM’s medical microneedling products globally.

As agreed, Candela will commercialise MT.DERM’s Exceed medical microneedling system used to treat facial wrinkles and facial acne scars.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The dual-indicated, FDA-cleared Exceed system will be first launched in the US, followed by distribution in other countries. The system has also secured CE marking in Europe.

Candela CEO Geoffrey Crouse said: “We are delighted to enter into a partnership with MT.DERM, based on their superior engineering and deep understanding of needling technology.

“Microneedling is an essential component of any medical aesthetics practice.  The addition of the Exceed medical microneedling system strengthens Candela’s product portfolio, which continues to provide customers the most comprehensive offering of best-in-class medical aesthetic technologies.”

Candela existing microneedling portfolio includes Profound system, which is a real-time, temperature-controlled, long pulse radiofrequency (RF) microneedling device.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

MT.DERM founder and CEO Joern Kluge said: “Candela and MT.DERM jointly have the industry experience and reputation to make the Exceed device a leader in the mechanical microneedling global market.”

The agreement between Candela and MT.DERM also includes the option to add new products for commercialisation in the future.

Candela operates as a global medical aesthetic device company marketing its products to 86 countries.

It specialises in offering solutions for medical aesthetic applications for traumatic and surgical scar treatments, women’s health treatments, wrinkle reduction and tattoo removal, among others.

Apex Partners acquired the company in July 2017.